Podocytes |
NPHS1/Nephrin |
Human/Mouse |
FP Effacement/Proteinuria |
NA |
At birth |
Kestila et. al (26) |
NPHS2/Podocin |
Human |
FP Effacement/Proteinuria |
NA |
Late |
Boute et. a (30) |
PLC epsilon 1 |
Human/Zebra Fish |
Diffuse Mesangial Sclerosis (DMS) |
NA |
Early |
Hinkes et. al (92) |
Nck |
Mouse |
FP Formation Defect |
NA |
At birth |
Jones et. al (53) |
Fyn |
Mouse |
Subtle changes in FP |
NA |
Early |
Yu et. al (56) |
Fyn/Yes Combined |
Mouse |
FP effacement/Proteinuria |
NA |
Early |
Stein et. al (32) |
Kirrel/Neph1 |
Mouse |
FP Effacement/Proteinuria |
NA |
Early |
Donoviel et. al (58) |
TRPC6 |
Human |
FSGS |
NA |
NA |
Winn et. al (65), Reiser et. al (66) |
Combined CD2ap/Fyn |
Mouse |
FSGS |
NA |
Late |
Huber et. al (47) |
ACTN4/Alpha-Actinin-4 |
Human/Mouse |
FSGS |
NA |
Late |
Kaplan et. al (64) |
Notch1 Transgenic |
Mouse |
FSGS |
NA |
NA |
Niranjan et. al (33) |
NFAT Transgenic |
Mouse |
FSGS |
NA |
Early |
Wang et. al (34) |
uPAR |
Mouse |
NA |
Protected |
NA |
Wei et. al (71) |
Focal Adhesion Kinase |
Mouse |
NA |
Protected |
NA |
Ma et. al (70) |
COQ2/Coenzyme Q10 |
Human |
FSGS |
NA |
Late |
Scalgia et. al (36) |
HGF/C-met |
Mouse |
Normal |
injury and proteinuria following adriamycin |
|
Dai et. al (48) |
aPKC Lambda/iota |
Mouse |
FSGS/FP Effacement/Proteinuria |
NA |
Late |
Huber et. al(61), Hirose et. al (62) |
PDSS2/Prenly Diphosphate Synthase Subunit 2 |
Human/Mouse |
FP effacement/Proteinuria |
NA |
Late |
Peng et. al (37) |
Synaptopodin |
Mouse |
Normal |
Slow Recovery |
NA |
Asanuma et al (40) |
Cfl1/Cofilin 1 |
Mouse/Zebra Fish |
FP Effacement/Proteinuria |
process morphology |
Late |
Garg et. al (50), Ashworth et. al. (60) |
Sidekick Transgene |
Mouse |
FSGS |
NA |
Late |
Kaufman et. al (49) |
INF2 |
Human |
FSGS |
NA |
Late |
Brown et. al (68) |
ATG5 |
Mouse |
Glomerulosclerosis/Proteinuria |
NA |
Late |
Hartleben et. al (90) |
PI3Kc II |
Mouse |
DMS/FP effacement/Proteinuria |
NA |
Late |
Harris et. al (91) |
EP4 receptor Transgenic |
Mouse |
Proteinuria |
5/6 th Nephrectomy required |
NA |
Stitt-Cavanagh et. al (39) |
AT1 Transgenic |
Mouse |
FP Effacement |
NA |
Early |
Hoffman et. al (41) |
Beta Catenin |
Mouse |
NA |
Protected |
NA |
Dai et. al (42) |
Podocalyxin Transgenic |
Mouse |
FP formation Defect |
NA |
NA |
Economou et al. (43) |
FAT1 |
Mouse |
FP Effacement/Proteinuria |
NA |
Perinatal Lethality |
Ciani et. al (59) |
GLEPP1 |
Mouse |
Broadening of FP/No Proteinuria |
NA |
NA |
Wharram et. al (35) |
VEGF transgenic |
Mouse |
Collapsing glomeruolopathy |
NA |
Early |
Eremina et. al (44) |
VEGF Heterozygous deletion |
Mouse |
Endotheliosis/Proteinuria |
NA |
Early |
Eremina et. al (44) |
Glomerular Basement Membrane |
Lamb2/Laminin β2 |
Human/Mouse |
DMS/FSGS (Pierson syndrome) |
NA |
Perinatal Lethality |
Jarad et. al (15) |
Beta 1 Integrin |
Mouse |
Proteinuria |
NA |
At Birth |
Pozzi et. al (46) |
Integrin alpha 3 subunit |
Mouse |
Disorganized GBM/FP formation defect/Proteinuria |
NA |
Early |
Kang et. al (101) |
Integrin Linked Kinase |
Mouse |
GBM alteration/FSGS |
NA |
Early |
El Aouni et. al (102) |
Tubules |
Cubulin |
Mouse |
Normal/Minimal Proteinuria |
NA |
NA |
Amsellen et. al (109) |
Megalin |
Mouse |
LMW proteinuria |
NA |
Early |
Leheste et. al (45) |
Transcription Factors |
WT1 |
Human |
Denys Drash and Frasier Syndrome |
NA |
Early |
Yang et. al (88), Guo et. al (89) |
PTIP |
Mouse |
Proteinuria |
NA |
Late |
LeFevre et. al (87) |
LMX1B/LIM homeobox transcription factor |
Human |
Nail Patella syndrome |
NA |
Early |
Rohr et al. (80) |
SMARCAL1 |
Human |
FSGS/Steroid Resistant NS |
NA |
Late |
Boerkoel et al.(77) |